Kabelline is a widely known Korean deoxycholic acid (DCA) injectable for localized fat reduction, sold in 8 ml vials packed in boxes. DCA is a bile acid that disrupts fat-cell membranes. This is a medical procedure that belongs to a licensed professional, not a DIY routine, and the official guide is attached for your records.

What is Kabelline, and how does its maker describe it?

Kabelline is a lipolytic, an injectable formulated to reduce small, stubborn pockets of fat. Its active ingredient is deoxycholic acid, a bile acid your body already produces to emulsify dietary fat. The product comes in 8 ml vials sold in multi-vial boxes, and it is one of the more recognized DCA brands coming out of Korea.

The manufacturer’s stated mechanism goes like this: deoxycholic acid draws water into the fat cells so they burst from the inside, after which the cellular debris is cleared away through the lymphatic system and by macrophages, the body’s cleanup cells. The maker also claims Kabelline causes less swelling and bruising than older phosphatidylcholine (PPC) formulas. Read those as the manufacturer’s claims, not settled fact.

Log Notes. This page explains what Kabelline is and the mechanism its maker describes. It gives no doses, volumes, injection sites, depths, session counts, or technique. Those belong to a licensed professional and the official guide, not a blog. Nothing here is medical advice, and injectable lipolysis is never a do-it-yourself procedure.

Is Kabelline FDA-approved, and what are the risks?

Here is the honest part. Deoxycholic acid is the only fat-dissolving ingredient with FDA approval, marketed as Kybella, and that approval is limited to fat under the chin (submental fat), not the body or jawline contouring. Korean DCA products like Kabelline are generally not FDA-approved, so any use sits outside that narrow clearance.

The FDA is blunt about the wider category. It warns that fat-dissolving injections that are not FDA-approved can be harmful and that the agency cannot confirm their safety, quality, or effectiveness. Injectable lipolysis carries genuine risks, including swelling, bruising, lumps, nerve injury, and uneven results. A gentler marketing pitch does not change the fact that this is a medical procedure with real downsides, decided and performed only by a qualified professional.

What should you expect, and what is worth tracking?

Slow change and a steady record. Lipolysis is usually discussed as a course of visits, and any reduction in a treated area appears gradually over weeks, not on the day itself. That timeline makes a dated log far more useful than memory, and far more honest than a single flattering photo.

This is where Dosefi fits a careful routine. If you pursue Kabelline with a licensed professional, you log each session with its date and a photo, set a reminder for the review window your provider gives you, and self-rate the treated area so trends build over the weeks that follow. A log never makes a procedure safe; it simply keeps your own history organized.

Because so many of these injectables share an active ingredient, comparing them sharpens your questions. Our notes on the high-volume DCA product BO-DCA and the carnitine-and-B12 blend Red Line show how the same bile acid gets positioned in different ways.

A grounded takeaway

Kabelline is a deoxycholic acid lipolytic in 8 ml vials, marketed as a gentler DCA option for localized fat. The honest bottom line is regulatory: deoxycholic acid is FDA-approved only for under-chin fat as Kybella, Korean brands like this are generally not approved, and the FDA warns non-approved fat-dissolving injections can be harmful. Leave candidacy and the procedure to a licensed professional. The guide is attached for reference only.

Sources